| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.098 | 0.1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |